Methodology
Every price on this site is a figure we can point to a source for. Treatment prices come from supplier pricing supplied to us. Scheme figures come from the HSE and Citizens Information. Clinical statements come from the European Medicines Agency and the HPRA. Where we are unsure, we say so rather than estimating.
Where treatment prices come from
The prices published on our product pages are supplier pricing, listed by pack and by strength exactly as supplied. We show the pack size beside every figure, because a price without a pack size is meaningless.
Irish pharmacy retail prices vary. We say so on every page rather than presenting one number as the price.
What we exclude from the headline treatment price
The published price is medication only. These sit outside it because they vary by person rather than by product:
- Consultation fees, typically €35 to €90 privately or €50 to €70 at a GP
- Baseline bloods and monitoring, usually €60 to €100
- Delivery, where a pharmacy offers it
- Sharps disposal
We list those separately on each page so the real total is visible.
Where our Irish scheme and clinical information comes from
| Subject | Source |
|---|---|
| Drugs Payment Scheme, medical card, Long Term Illness | HSE and Citizens Information |
| Licensing and authorisation status | HPRA authorised medicines register |
| Dosing, titration, side effects | European Medicines Agency product information |
| Enforcement and illegal supply | HPRA published enforcement reports |
| Trial outcomes | Published trial literature, named in the text |
We link out to these directly rather than paraphrasing without attribution.
How we handle uncertainty in pricing data
Three rules we hold to.
- If we cannot source it, we do not publish it. A plausible-sounding number with no source is worse than no number.
- Ranges stay ranges. Consultation costs genuinely vary, so we publish the range rather than picking a midpoint and presenting it as fact.
- We do not publish per-month figures we cannot verify. Converting pack prices to monthly costs requires dose counts we have not confirmed, so we publish per pack instead.
What we will not publish about weight loss treatment
- Customer reviews, testimonials or star ratings we have not genuinely received
- Named clinicians or registration numbers that are not ours to publish
- Claims about our own regulatory status beyond what is true
- Individual dose recommendations. We show the published titration schedule and nothing more
Reporting an error in our Irish price data
Email ventes@slim4medoc.com
ordonnance@slim4medoc.com with the page and the figure. If you have a source showing we are wrong, include it and we will correct faster.
Corrections are logged publicly on our .
Why our prices differ from what you are quoted
They will sometimes, and it is worth understanding why before you assume one of us is wrong. Ireland does not fix the retail price of a prescription medicine that is not being reimbursed. Each pharmacy sets its own dispensing fee and its own margin, so the same pack can differ by €40 or more between two pharmacies in the same city.
Our figures are a reference point, not a promise. Use them to know roughly what you should be paying and to recognise a quote that is well out of line, then confirm the exact number with the pharmacy that will dispense to you.
How often this is checked
Treatment prices are reviewed whenever supply pricing moves. Scheme thresholds, such as the €80 Drugs Payment Scheme cap and the €1.50 medical card charge, are checked against HSE publications and updated the week a change is announced.
Clinical figures, such as trial averages and titration schedules, come from each product’s Summary of Product Characteristics or the published trial, and change only when the manufacturer or the regulator changes them. Every page shows the date it was last updated.
What we deliberately leave out
- Anything we cannot source. If we cannot point to where a figure came from, it does not go on the page.
- Individual results. Trial averages are reported as averages, never as what you should expect.
- Comparisons the data does not support. Ozempic’s weight figures come from diabetes trials at lower doses, so they are not directly comparable to Wegovy’s, and we say so rather than putting them in the same column.